상세 보기
자료 필터
자료유형
발행연도
1994 ~ 2036
1994 2036
키워드
언어
선택된 필터
- article
- conference
- book
전체 241건 중 1번부터 10번까지의 결과를 표시합니다.
2026
Article
OPTIMAL: A Multinational Phase III Study of Oral Paclitaxel (DHP107) versus Intravenous Weekly Paclitaxel in HER2-Negative Recurrent or Metastatic Breast Cancer
- Xu, B ;
- Jeong, H ;
- Sun, T ;
- Sohn, J ;
- Zhang, Q ;
- ... Seo, J H ;
- 외 15명
- 2026-07
- Annals of Oncology
- Oxford University Press
Article
Ebastine targets HER2/HER3 signaling and cancer stem cell traits to overcome trastuzumab resistance in HER2-positive breast cancer
- Jung, Eun Sun ;
- Kim, Ji Young ;
- Ko, Dongmi ;
- Seo, Juyeon ;
- Lee, Sang Yoon ;
- ... Lee, Kyoungmin ;
- ... Nam, Kee Dal ;
- ... Kim, Yoon-Jae ;
- ... Seo, Jae Hong ;
- 외 6명
- 2026-04
- International Journal of Molecular Medicine
- Demetrios A. Spandidos Ed. & Pub.
Article
C‑terminal HSP90 inhibitor NCT‑58 impairs the cancer stem‑like phenotype and enhances chemotherapy efficacy in TNBC
- Jung, Eunsun ;
- Kim, Yoon-Jae ;
- Lee, Kyoungmin ;
- Jang, Seojin ;
- Park, Soeun ;
- ... Nam, Kee Dal ;
- ... Kim, Ji Young ;
- ... Seo, Jae Hong ;
- 외 10명
- 2026-01
- Oncology Reports
- Demetrios A. Spandidos Ed. & Pub.
2025
Article
Pitavastatin is a novel Mcl-1 inhibitor that overcomes paclitaxel resistance in triple-negative breast cancer
- Ko, Dongmi ;
- Park, Soeun ;
- Park, Minsu ;
- Kim, Seongjae ;
- Park, Jung Min ;
- ... Nam, Kee-dal ;
- ... Jung, Eunsun ;
- ... Kim, Yoon-jae ;
- ... Kim, Ji-young ;
- ... Seo, Jae Hong Ong ;
- 외 3명
- 2025-12
- Experimental Hematology & Oncology
- BioMed Central
Conference
Phase III of oral paclitaxel (DHP107) vs intravenous paclitaxel in HER2-negative recurrent or metastatic breast cancer (mBC): Primary analysis of a multinational optimal trial (NCT03315364).
- Kim, Sung-Bae ;
- Xu, Binghe ;
- Sun, Tao ;
- Zhang, Qingyuan ;
- Kostic, Sanja ;
- ... Seo, Jae Hong ;
- 외 14명
- 2025-06-01
- 미국
Article
Retraction: Promoter methylation of RASSF1A modulates the effect of the microtubule-targeting agent docetaxel in breast cancer
- Gil, Eun Young ;
- Jo, Uk Hyun ;
- Jeong, Hoiseon ;
- Whang, Young Mi ;
- Woo, Ok Hee ;
- ... Cho, Kyu Ran ;
- ... Seo, Jae Hong ;
- ... Kim, Aeree ;
- ... Park, Kyong Hwa ;
- 외 3명
- 2025-05
- International Journal of Oncology
- Demetrios A. Spandidos Ed. & Pub.
Article
Corrigendum to “Discovery of indazole inhibitors for heat shock protein 90 as anti-cancer agents” [Eur. J. Med. Chem. (2024) 116620]
- La, Minh Thanh ;
- Hoang, Van-Hai ;
- Sahu, Raghaba ;
- Nguyen, Cong-Truong ;
- Nam, Gibeom ;
- ... Kim, Yoon-Jae ;
- ... Seo, Jae Hong ;
- 외 5명
- 2025-02
- European Journal of Medicinal Chemistry
- Elsevier BV
2024
Conference
Real-world safety and effectiveness of ribociclib in Korean patients with HR+/HER2-locally advanced or metastatic breast cancer
- Kim, J. H. ;
- Chang, M-C. ;
- Kim, T-H. ;
- Seo, J. H. ;
- Kim, J-J. ;
- 외 5명
- 2024-12
- 네덜란드
Article
Discovery of indazole inhibitors for heat shock protein 90 as anti-cancer agents
- La, Minh Thanh ;
- Hoang, Van-Hai ;
- Sahu, Raghaba ;
- Nguyen, Cong-Truong ;
- Nam, Gibeom ;
- ... Kim, Yoon-Jae ;
- ... Seo, Jae Hong ;
- 외 5명
- 2024-10
- European Journal of Medicinal Chemistry
- Elsevier BV
Article
Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance study
- Park, Min Ho ;
- Seo, Jae Hong ;
- Park, Jung Ho ;
- Seong, Min-Ki ;
- Park, Keon Uk ;
- 외 16명
- 2024-04
- Expert Opinion on Biological Therapy
- Ashley Publications Ltd.